Overview

Description

  • NatureSynthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab48695 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-ENT2 antibody (ab48595)

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • 36 kDa
    • 36 kDa nucleolar protein HNP36
    • Delayed-early response protein 12
    • DER12
    • ei-type
    • Equilibrative NBMPR-insensitive nucleoside transporter
    • Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter
    • Equilibrative nucleoside transporter 2
    • HNP36
    • Hydrophobic nucleolar protein
    • Hydrophobic nucleolar protein, 36 kDa
    • Nucleoside transporter
    • S29A2_HUMAN
    • SLC29A2
    • solute carrier family 29 (nucleoside transporters), member 29
    • Solute carrier family 29 member 2
    see all
  • FunctionMediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.
  • Tissue specificityExpressed in skeletal muscle, liver, lung, placenta, brain, heart, kidney and ovarian tissues.
  • Sequence similaritiesBelongs to the SLC29A/ENT transporter (TC 2.A.57) family.
  • Cellular localizationBasolateral cell membrane. Nucleus membrane. Localized at the basolateral cell membrane in polarized MDCK cells.
  • Information by UniProt

References for Human ENT2 peptide (ab48695)

ab48695 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab48695.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"